Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.

Melvin JC, Garmo H, Holmberg L, Hammar N, Walldius G, Jungner I, Lambe M, Van Hemelrijck M.

BMC Cancer. 2017 Apr 4;17(1):246. doi: 10.1186/s12885-017-3232-6.

2.

Risk Factors for 30-Day Hospital Re-Admission with an Infectious Complication after Lower-Extremity Vascular Procedures.

Melvin JC, Smith JB, Kruse RL, Vogel TR.

Surg Infect (Larchmt). 2017 Apr;18(3):319-326. doi: 10.1089/sur.2016.234. Epub 2017 Feb 8.

3.

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.

Melvin JC, Purushotham AD, Garmo H, Pinder SE, Fentiman IS, Gillett C, Mera A, Lüchtenborg M, Holmberg L, Van Hemelrijck M.

Br J Cancer. 2016 Jun 14;114(12):e23. doi: 10.1038/bjc.2016.135. Epub 2016 May 26. No abstract available.

4.

Family history of breast cancer and its association with disease severity and mortality.

Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, Gillett C, Mera A, Holmberg L, Van Hemelrijck M.

Cancer Med. 2016 May;5(5):942-9. doi: 10.1002/cam4.648. Epub 2016 Jan 22.

5.

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.

Melvin JC, Purushotham AD, Garmo H, Pinder SE, Fentiman IS, Gillett C, Mera A, Lüchtenborg M, Holmberg L, Van Hemelrijck M.

Br J Cancer. 2016 Jan 12;114(1):88-95. doi: 10.1038/bjc.2015.314. Epub 2015 Dec 10. Erratum in: Br J Cancer. 2016 Jun 14;114(12):e23.

6.

Serum glucose and risk of cancer: a meta-analysis.

Crawley DJ, Holmberg L, Melvin JC, Loda M, Chowdhury S, Rudman SM, Van Hemelrijck M.

BMC Cancer. 2014 Dec 19;14:985. doi: 10.1186/1471-2407-14-985.

7.

An investigation into the relationship between statins and cancer using population-based data.

Melvin JC, Garmo H, Daniel R, Shanmugalingam T, Stattin P, Häggström C, Rudman S, Holmberg L, Van Hemelrijck M.

BJU Int. 2015 Nov;116(5):681-3. doi: 10.1111/bju.12935. Epub 2015 May 13. No abstract available.

8.

Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Melvin JC, Holmberg L, Rohrmann S, Loda M, Van Hemelrijck M.

J Cancer Epidemiol. 2013;2013:823849. doi: 10.1155/2013/823849. Epub 2013 Jan 20.

9.

Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.

Melvin JC, Rodrigues C, Holmberg L, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Jassem W, Van Hemelrijck M.

Int J Mol Epidemiol Genet. 2012;3(4):276-85. Epub 2012 Nov 15.

10.

Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children.

Lautz TB, Keys LA, Melvin JC, Ito J, Superina RA.

J Am Coll Surg. 2013 Jan;216(1):83-9. doi: 10.1016/j.jamcollsurg.2012.09.013. Epub 2012 Nov 21.

PMID:
23177370
11.

Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.

Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Wigertz A, Van Hemelrijck M.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1381-4. doi: 10.1158/1055-9965.EPI-12-0188. Epub 2012 May 16.

Supplemental Content

Loading ...
Support Center